Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers [NA]

View source ↗

Summary

Clinical trial update noting that Omeza's OCM (Omeza Complete Matrix) is being studied for treating diabetic foot ulcers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCM (Omeza Complete Matrix)

Snippet

Sponsor: Omeza, LLC | Conditions: Diabetic Foot Ulcer | NA | Status: RECRUITING